Products and Resources Catalog

COURSE DESCRIPTION This presentation reviews the history of US street drug markets since the early 1990s to explain the emergence of xylazine, fentanyl, and crystal methamphetamine in regional markets formerly dominated by heroin and cocaine. It will examine the relationship between each of these newly prevalent synthetic substances and describe what we know so far about their impact on related comorbidities. Finally, it will assess how the public health impact of recent transformations to the US narcotics supply relates to the experience of drug consumption and the actual way that people use drugs in their everyday lives. It will conclude with lessons learned to help determine what prevention strategies could be used to counteract the impact on communities. Select the View Resource button above to watch the recording and link to the PowerPoint below. PowerPoint PRESENTER Dr. Fernando Montero’s research draws together the methods of medical and economic anthropology to examine the racialized, gendered interface between the opioid overdose epidemic, mass incarceration, ongoing transformations in narcotics supply chains, and public assistance programs for psychiatric disability in the United States. His mixed-methods research studies the changes in the risk environment for HIV, HCV, mental health conditions, and fatal overdose among street-based drug users brought about by the emergence of synthetic sedatives (e.g. fentanyl and xylazine) and stimulants (e.g. methamphetamine) in the 2010s-2020s, and by the concomitant resurgence of punitive drug control targeting petty dealers throughout the US. One of the central questions of his current research is why the opioid overdose epidemic is becoming increasingly black following almost three decades in which it was predominantly white and working class. He is also conducting a long-term ethnographic study of the War on Drugs in the Afro-Indigenous region of Moskitia on the Caribbean Coast of Nicaragua and Honduras.      

Xylazine: What We Know About the Latest Substance Trend Josh Esrick, MPP, Emily Patton, MSc, PgDip, and Deborah Nixon Hughes, LCSW-C October 18, 2023, 12:00pm-1:30pm EST COURSE DESCRIPTION Xylazine is an emerging issue across the United States, often used in conjunction with opioids and other substances. Public health professionals must be aware of Xylazine’s effects and how it complicates efforts to prevent and treat other substance use. This presentation summarizes the available research and data on xylazine use. LEARNING OBJECTIVES Discuss the available data on xylazine use and consequences in the United States Describe the impacts of xylazine use Explain harm reduction strategies related to xylazine use Recommend strategies for developing a culturally responsive and relevant public health approach to xylazine use PRESENTERS Josh Esrick, MPP is the Chief of Training and Technical Assistance at Carnevale Associates, LLC. Mr. Esrick has over ten years of experience researching, writing, evaluating, and presenting on substance use prevention and other behavioral health topics. He is an expert in providing training and technical assistance (T/TA) in substance use, having overseen the development of hundreds of T/TA products for numerous clients, including six of SAMHSA’s ten regional Prevention Technology Transfer Centers (PTTCs), the PTTC Network Coordinating Office, the Central East Addiction Technology Transfer Center (ATTC) and Mental Health Technology Transfer Centers (MHTTC), and SAMHSA’s Center for the Application of Prevention Technologies (CAPT). These trainings and products have covered a wide range of topics, including strategic planning, data collection and analysis, and identifying evidence-based prevention interventions for youth. In addition to T/TA, Mr. Esrick has directly provided many of these services to behavioral health agencies and other entities. He has published several academic journal articles. He holds a Bachelor of Arts in Political Science from the State University of New York at Buffalo and a Master of Public Policy from George Washington University.     Emily Patton, MSc, PgDip holds a Masters of Science in Abnormal and Clinical Psychology from Swansea University and a Postgraduate Degree in Criminology and Criminal Justice from the University of Edinburgh. She offers significant professional experience in the fields of public policy development and analysis, criminal justice research, data collection and analysis, program development, and performance management.         Deborah Nixon-Hughes, LCSW-C, is the Project Director for the Central East Prevention Technology Transfer Center (PTTC). She is responsible to use proven technology transfer strategies and practices to promote the adoption and implementation of evidence-based prevention and early intervention approaches. Debbie will be the spokesperson and liaison to federal, regional, state and local entities; academic institutions; and prevention, treatment, and/or recovery agencies. Deborah is responsible to identify prevention needs through engaging and collaborating with primary care providers; individuals experiencing behavioral health challenges and their families; and other community stakeholders/systems. As a result, she recommends and coordinates workforce trainings and technical assistance initiatives that can address the needs identifies, and thus reduce the effect of mental and substance use disorders on the health of individuals, their families, and their communities.  

Learn more about Prevention in Action exploring Drug Take Back Day events and related efforts to reduce the illicit use of prescription medications across New England. This webinar includes a spotlight on what coalitions around the region are doing to support drug take-back as well as a presentation from the DEA on their new and ongoing initiatives.   Link to view the recorded webinar (recorded on October 27, 2022). No continuing education is available.   

In This Issue: National Prevention Week Epi Corner: What We Have Learned About the Prevention and Treatment of Opioid Use Disorder (OUD) "What we give them", A poem about prevention What's Happening Around the Region? Register for Part 3 Ditching the Discomfort with Data, Working With Data PTTC Spotlights Latino Behavioral Health Equity Conference Resources: Online Registry for Substance Misuse Prevention Evidence-based Programs and Practices Funding Opportunities

In This Issue:   National Prevention Week   Epi Corner: What We Have Learned About the Prevention and Treatment of Opioid Use Disorder (OUD)   "What we give them", A poem about prevention   What's Happening Around the Region? Register for Part 3 Ditching the Discomfort with Data, Working With Data   PTTC Spotlights Latino Behavioral Health Equity Conference Resources: Online Registry for Substance Misuse Prevention Evidence-based Programs and Practices   Funding Opportunities

La prevención de sobredosis por uso de opioides requiere la colaboración de una amplia gama de socios, muchos de los cuales pueden ser nuevos para los proveedores de servicios de prevención.   Click here to download resource. 

*This webinar was in Spanish* Presentación El Abuso de Sustancias Durante El COVID-19 es una presentación que introduce a Los Centros Hispano/Latino de Capacitación y Asistencia Técnica en Adicción y en Prevención (NHL-ATTC y NHL-PTTC) de SAMHSA a los miembros de los programas de La Ventanilla de Salud (VDS), un programa diseñado por la Secretaría de Salud y la Secretaría de Relaciones Exteriores del Gobierno de México para ayudar a identificar los servicios de salud que necesitan las familias mexicanas en Estados Unidos dentro del Consulado de México. La VDS ofrece educación en distintos temas de salud. El objetivo de la VDS es mejorar el acceso a servicios primarios y preventivos de salud, aumentar la cobertura en seguros públicos y promover una cultura de prevención de salud a los mexicanos que viven en Estados Unidos. Por medio de este taller educativo, los miembros de los centros proveen información sobre los centros NHL-PTTC) y NHL-ATTC con el propósito de formar enlaces con las 50 sucursales de VDS ubicadas por todo el país. El taller también ofrece información sobre la prevención del abuso de sustancias, define que es la prevención, presenta la Prevención como disciplina o profesión y ofrece información y recursos sobre la prevención. Finalmente presenta información sobre los trastornos del abuso de sustancias, y como aprender sobre las causas, consecuencias y tratamientos disponibles sobre ellos. Y una sección de información sobre retos del COVID-19 y el uso de sustancias y ofreció recursos para la comunidad.

The September 2019 Dialogue contains articles on: Addiction: National Recovery Month | Mental Health: Learning Collaboratives | Prevention: Prescription Opioid and Heroin Awareness | ORN: LGBT+ Long-term Recovery | Recovery Stories Additional sections include upcoming training and webinar events, behavioral health observances, new resources, and Region 3 news. The Dialogue is designed to inform behavioral and mental health professionals of news and upcoming events in the Central East states. This electronic newsletter is disseminated on the first Tuesday of each month. You are encouraged to provide us with any feedback or submit articles and topics for discussion in future issues of the newsletter. If you would like to be added to our mailing list to receive the Dialogue, news, and training announcements, sign up here.       Recovery Stories: Two special guest contributors shared their recovery stories for Recovery Month in the September Dialogue.   Shirley J. Davis For many years, I ran from the realities of my past life and tried extremely hard to hide from the knowledge that I continually lost time and felt like “someone else,” until the winter of my thirtieth year. I went to bed one night and as soon as I turned off the light to go to sleep, I relived a horrible memory of rape. I immediately turned the lights back on and lay shivering in my bed waiting for daylight. It was then that I knew I had to get help. Continue reading Shirley's story.     Kathy Dorman I’m so grateful to be a recovering addict, to still be alive to give others hope, because I remember the life of hopelessness. My passion is to reach children and young adults who may feel hopeless or peer pressured into trying drugs. As a child, I was surrounded by family and friends who were caught in the disease of addiction. I tell people, yes, I may have had a choice, but literally I had no chance, at least that’s how I felt. Continue reading Kathy's story.

Scope of Prevention 5-Part Webinar Series Part 3 of 5 Preventing Relapse by Providing Comprehensive Oral Health Care with Substance Use Disorder Treatment The University of Utah, School of Dentistry has demonstrated an important role for oral health in managing substance-use disorder patients by identifying dramatic increases in treatment length of stay, their ability to obtain employment, as well as a decrease in their homelessness and drug-use, by providing comprehensive dental care as an integrated part of their substance-use management. This webinar will highlight the School of Dentistry's program and provide discussion of research, findings, and implications.  PDF Slides Presenter: Glen Hanson, PhD, DDS